Robuta

Sponsor of the Day: Jerkmate
https://www.facs.org/for-medical-professionals/news-publications/news-and-articles/acs-brief/march-24-2026-issue/deceased-donor-livers-have-survival-benefit-in-patients-with-unresectable-colorectal-liver-metastases/ Deceased Donor Livers Have Survival Benefit in Patients with Unresectable Colorectal Liver... Deceased donor liver transplant shows promising survival outcomes for colorectal liver metastases, expanding access beyond prior limitations. deceaseddonorliverssurvivalbenefit https://www.fda.gov/news-events/press-announcements/fda-approves-first-cellular-therapy-treat-patients-unresectable-or-metastatic-melanoma FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma | FDA The FDA approved Amtagvi, the first cellular therapy for the treatment of adults with unresectable or metastatic melanoma previously treated with a PD-1... fda approves firstcellular therapytreat patientsunresectablemetastatic https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-chemotherapy-unresectable-advanced-or-metastatic-malignant-pleural FDA approves pembrolizumab with chemotherapy for unresectable advanced or metastatic malignant... On September 17, 2024, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) with pemetrexed and platinum chemotherapy as first-line... fda approvespembrolizumabchemotherapyunresectableadvanced